Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesTerbinafine: a pharmacological and clinical review
Expert Opinion in Pharmacotherapy, 11/03/09
Krishnan–Natesan S – Terbinafine has established itself as a drug of choice for dermatophytic infections; it must be considered in combination with other antifungal agents for the management of nondermatophytic refractory or resistant yeast/mold infections as well.
Related Articles
Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study
British Journal of Dermatology, 10/07/09
Relevance Score: 84%
Terbinafine (250 mg/day): an effective and safe treatment of cutaneous sporotrichosis
Journal of the European Academy of Dermatology and Venereology, 10/26/09
Relevance Score: 83%
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis
Clinical and Experimental Dermatology, 11/02/09
Relevance Score: 82%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Cytotoxic and antibacterial activities of endophytic fungi isolated from plants at the National Park, Pahang, Malaysia
BMC Complementary and Alternative Medicine, 11/24/09
The Hemostatic Balance in HIV-Infected Patients with and without Antiretroviral Therapy: Partial Restoration with Antiretroviral Therapy
AIDS Patient Care and STDs, 11/24/09
Antiretroviral Drug-Resistant Mutations at Baseline and at Time of Failure of Antiretroviral Therapy in HIV Type 1-Coinfected TB Patients
AIDS Research and Human Retroviruses, 11/24/09
Sponsor
Article Search
Sponsor